Sizaret P
Bull World Health Organ. 1988;66(1):1-6.
The main activities in international biological standardization during the 18 years that followed the first international biological standardization meeting in London in 1921 were concerned with expressing the potencies of test preparations in comparison with reference materials. After the Second World War, however, it became clear that the testing of biological substances against international reference materials was only one among several measures for obtaining safe and potent products. The activities in international biological standardization were therefore widened so that, by the strict observance of specific manufacturing and control requirements, it was possible to gain further in safety and efficacy. At the end of 1987, 42 international requirements for biological substances were available and were being used as national requirements, sometimes after minor modification, by the majority of WHO's Member States. This is of utmost importance for the worldwide use of safe and potent biological products, including vaccines.
1921年在伦敦召开首次国际生物标准化会议后的18年里,国际生物标准化的主要活动是将试验制剂的效价与参考物质相比较来表示。然而,第二次世界大战后,很明显,对照国际参考物质对生物制品进行检测只是获得安全且高效产品的若干措施之一。因此,国际生物标准化活动得以扩展,以便通过严格遵守特定的生产和控制要求,在安全性和有效性方面取得进一步进展。到1987年底,已有42项生物制品国际要求,大多数世界卫生组织成员国有时在略作修改后将其用作本国要求。这对于包括疫苗在内的安全且高效的生物制品在全球的使用至关重要。